FTY720
Side effects
Options:
Show MedDRA Preferred Terms
Side effect
|
Data for drug
|
Placebo
|
Labels
|
|
1
|
2
|
3
|
4
|
Infection
|
2% - 72%
|
|
x
|
x
|
x
|
x
|
Headache
|
very common, 25% - 25.2%
|
23%
|
x
|
x
|
x
|
x
|
Alanine aminotransferase increased
|
very common
|
|
|
x
|
|
|
Hepatic enzyme increased
|
very common
|
|
|
x
|
|
x
|
Aspartate aminotransferase increased
|
14%
|
5%
|
x
|
|
|
|
Influenza viral infections
|
very common, 9.32% - 13%
|
9.81% - 10%
|
x
|
|
|
x
|
Influenza
|
12.9%
|
|
x
|
x
|
x
|
x
|
Cough
|
very common, 10%
|
8%
|
x
|
x
|
x
|
x
|
Back pain
|
very common, 11.8% - 12%
|
7%
|
x
|
x
|
x
|
x
|
Diarrhoea
|
very common, 11.8% - 12%
|
7%
|
x
|
x
|
x
|
x
|
Herpes NOS
|
8.71%
|
|
|
|
x
|
|
Bronchitis
|
common, 8% - 9.09%
|
3.59% - 4%
|
x
|
x
|
x
|
x
|
Dizziness
|
common, 7% - 7.29%
|
6%
|
x
|
x
|
x
|
x
|
Herpes virus infection
|
common, 9%
|
8%
|
x
|
x
|
x
|
x
|
Sinusitis
|
6.59% - 7%
|
5%
|
x
|
x
|
x
|
x
|
Depression
|
common, 8%
|
7%
|
x
|
x
|
x
|
x
|
Dyspnoea
|
common, 8%
|
5%
|
x
|
x
|
x
|
x
|
Hypertension
|
common, 6%
|
4%
|
x
|
x
|
x
|
x
|
Paraesthesia
|
5% - 5.41%
|
4%
|
x
|
|
x
|
x
|
Atrioventricular block
|
common
|
|
x
|
x
|
x
|
x
|
Tinea versicolour
|
common
|
|
|
x
|
|
|
Migraine
|
common, 4.71% - 5%
|
1%
|
x
|
x
|
x
|
x
|
Gamma-glutamyltransferase increased
|
5%
|
1%
|
x
|
|
|
|
Weight decreased
|
4.71% - 5%
|
3%
|
x
|
|
x
|
x
|
Gastroenteritis
|
4.47% - 5%
|
3%
|
x
|
|
x
|
x
|
Lymphopenia
|
common, 4%
|
1%
|
x
|
x
|
x
|
x
|
Vision blurred
|
common, 4%
|
1%
|
x
|
x
|
x
|
x
|
Alopecia
|
common, 3.53% - 4%
|
2%
|
x
|
x
|
x
|
x
|
Leukopenia
|
common, 3%
|
1%
|
x
|
x
|
x
|
x
|
Bradycardia
|
common, 3.53% - 4%
|
1%
|
x
|
x
|
x
|
x
|
Blood triglycerides increased
|
common, 3%
|
1%
|
x
|
x
|
|
x
|
Tinea infection
|
3.76% - 4%
|
1%
|
x
|
|
x
|
x
|
Eczema
|
common, 3% - 3.29%
|
2%
|
x
|
x
|
x
|
x
|
Asthenia
|
common, 2.59% - 3%
|
1%
|
x
|
x
|
x
|
x
|
Pruritus
|
common, 2.59% - 3%
|
1%
|
x
|
x
|
x
|
x
|
Eye pain
|
3%
|
1%
|
x
|
|
x
|
x
|
Macular oedema
|
uncommon
|
|
x
|
x
|
x
|
x
|
Depressed mood
|
uncommon
|
|
|
x
|
|
|
Neutrophil count decreased
|
uncommon
|
|
|
x
|
|
|
Pneumonia
|
uncommon, 0.471%
|
|
|
x
|
x
|
x
|
Autoimmune disorder
|
|
|
|
x
|
|
|
Mental disorder
|
|
|
x
|
x
|
x
|
x
|
Varicella
|
|
|
|
|
x
|
x
|
Connective tissue disorder
|
|
|
x
|
x
|
|
x
|
Acute disseminated encephalomyelitis
|
|
|
|
x
|
|
|
Eye disorder
|
|
|
x
|
x
|
x
|
x
|
Fatigue
|
|
|
|
x
|
|
|
Gastrointestinal disorder
|
|
|
x
|
x
|
x
|
x
|
Cardiac arrest
|
|
|
|
x
|
x
|
x
|
Cardiac disorder
|
|
|
x
|
x
|
x
|
x
|
Hypotension
|
|
|
|
x
|
|
|
Hemophagocytic lymphohistiocytosis
|
|
|
|
x
|
|
|
Lymphoma
|
|
|
x
|
x
|
x
|
x
|
Lymphoproliferative disorder
|
|
|
x
|
|
x
|
x
|
Mediastinal disorder
|
|
|
x
|
x
|
|
x
|
Nervous system disorder
|
|
|
x
|
x
|
x
|
x
|
Palpitations
|
|
|
|
x
|
|
|
Cerebrovascular accident
|
|
|
|
x
|
x
|
x
|
Angiopathy
|
|
|
x
|
x
|
x
|
x
|
Bradyarrhythmia
|
|
|
x
|
x
|
x
|
x
|
B-cell lymphoma
|
|
|
x
|
x
|
x
|
x
|
Atrioventricular block first degree
|
|
|
|
x
|
x
|
x
|
Lower respiratory tract infection
|
|
|
|
x
|
x
|
x
|
Atrioventricular block complete
|
|
|
|
x
|
x
|
x
|
Liver function test abnormal
|
|
|
|
|
|
x
|
Liver injury
|
|
|
x
|
|
|
|
Unspecified disorder of skin and subcutaneous tissue
|
|
|
x
|
x
|
x
|
x
|
Fatal outcomes
|
|
|
|
x
|
|
|
Visual acuity reduced
|
|
|
|
x
|
x
|
x
|
Atrioventricular block second degree
|
|
|
|
x
|
x
|
x
|
Wenckebach phenomenon
|
|
|
|
x
|
x
|
x
|
Herpes simplex encephalitis
|
|
|
|
|
x
|
x
|
Found dead (cause undetermined)
|
|
|
|
x
|
x
|
x
|
Mean arterial pressure
|
|
|
|
|
x
|
x
|
Pre-existing disease
|
|
|
|
x
|
x
|
x
|
Haemorrhagic stroke
|
|
|
x
|
|
|
|
Electrocardiogram PR prolongation
|
|
|
|
x
|
x
|
x
|
Varicella zoster
|
|
|
|
|
x
|
x
|
Infestation NOS
|
|
|
|
x
|
|
|
Blood and lymphatic system disorders
|
|
|
x
|
x
|
x
|
x
|
Multiple sclerosis relapse
|
|
|
|
|
x
|
x
|
Peripheral arterial occlusive disease
|
|
|
x
|
x
|
x
|
x
|
Posterior reversible encephalopathy syndrome
|
|
|
x
|
x
|
x
|
x
|
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Side effects: | 51 |
Source: | FDA Structured Product Label |
---|
Side effects: | 65 |
Source: | EMA |
---|
Side effects: | 61 |
Source: | Medsafe |
---|
Side effects: | 66 |
Source: | medicines.org.au |
---|
Color scheme:
standard – alternative
|
|
100%
|
|
|
75%
|
|
|
50%
|
|
|
10%
|
|
|
frequent (1% to 100%)
|
|
|
infrequent (0.1% to 1%)
|
|
|
rare (<0.1%)
|
|
|
postmarketing
|
|
|
0%
|
|
|
no frequency information
|
|
|
not found on label
|